Last update 08 May 2025

CD3ζ x 4-1BB x CD123 x EGFR T790M

Basic Info

Related Targets
CD3ζ4-1BBCD123[+1]

Related

1
Drugs associated with CD3ζ x 4-1BB x CD123 x EGFR T790M
Anti-CD123 CART(Affiliated Hospital to Academy of Military Medical Sciences)
Target
4-1BB x CD123 x CD3ζ x EGFR T790M
Mechanism
4-1BB modulators [+3]
Active Org.-
Originator Org.
Affiliated Hospital to Academy of Military Medical Sciences
Active Indication-
Inactive Indication-
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CD3ζ x 4-1BB x CD123 x EGFR T790M
NCT03114670
/ Unknown statusPhase 1IIT
Donor-derived Anti-CD123 Chimeric Antigen Receptors Modified T Cells for Recurred Acute Myeloid Leukaemia After Allogeneic Hematopoietic Stem Cell Transplantation
100 Clinical Results associated with CD3ζ x 4-1BB x CD123 x EGFR T790M
Login to view more data
100 Translational Medicine associated with CD3ζ x 4-1BB x CD123 x EGFR T790M
Login to view more data
0 Patents (Medical) associated with CD3ζ x 4-1BB x CD123 x EGFR T790M
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free